Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Microscope in a BioEscalator Lab


Oxford Cancer Analytics raises $3.7M led by Eka Ventures to revolutionise liquid biopsy and early cancer detection

Oxford Cancer Analytics is pioneering a new generation of blood-based liquid biopsy tests for early cancer detection. It has announced the completion of an additional seed financing round, led by Eka Ventures, with participation from LifeArc, MegaRobo Technologies, Oxford Technology Management, and value-add individual investors. The Oxford and Toronto-based company has raised $5.5M to date. It will invest in expanding its first-in-class international studies and developing products for the deadliest cancers that can benefit most from liquid biopsy early detection.

Oxford Cancer Analytics part of Oxford team that aims to detect lung cancer early via a simple blood test

A team of Oxford scientists and clinicians has launched a study to detect the early stages of lung cancer using a blood test and machine learning. The team from Oxford University Hospitals (OUH) NHS Foundation Trust, the Oxford Radcliffe Biobank and the local spin-out company Oxford Cancer Analytics (OXcan) will recruit 200 participants to identify cancer biomarkers - molecules such as proteins found in blood that are a sign of lung cancer. Oxford Cancer analytics joined the BioEscalator community in June 2022.

Alethiomics and Infinitopes shortlisted in the New Startup of the Year category for the Cancer Research Horizons Innovation & Entrepreneurship Awards 2022

Alethiomics is uncovering new biology to discover and develop life-changing treatments for patients with blood cancer, and Infinitopes is identifying hidden tumour targets, enabling the creation of high-efficiency vaccines.

Upcoming Events

BioEscalator Seminar Series: What apprenticeships can do for your company

Tuesday, 07 February 2023, 12.30pm to 2pm

How apprenticeships can help close the skills gap in the scientific sector and allow employers to build a workforce with future-ready skills

BioEscalator Mini Supplier Show

Tuesday, 21 February 2023, 10am to 3pm

Attending companies: Tech Comp, Swift Analytical, Fisher Scientific, and Thermo Scientific.

BioEscalator Team
Photograph of the BioEscalator building and adjoining carpark, taken from the top of the Kennedy building © BioEscalator Oxford